Latest

Parkinson’s disease

$This is a diagram from the study$

Featured Neuroscience Open Neuroscience Articles

·January 28, 2020·3 min read

New mathematical model for amyloid formation

Mathematical model describes the chemical reactions responsible for the formation of Alzheimer's-linked protein.

Featured Genetics Neurology Neuroscience

·January 27, 2020·5 min read

Parkinson’s disease may start before birth

10% of patients diagnosed with Parkinson's disease are between the ages of 21 and 50. For those with young-onset Parkinson's disease, researchers report the foundations for the disease may have been apparent before they were born. The study also points to a drug, currently approved to treat precancerous skin growths, that has the potential to reduce elevated levels of alpha-synuclein.

Featured Neurology Neuroscience Open Neuroscience Articles

·January 23, 2020·4 min read

Living near major roads linked to risk of dementia, Parkinson’s, Alzheimer’s and MS

Living less than 50 meters away from a major road, or less than 150 meters away from a highway, increases the risks for dementia, Alzheimer's disease, Parkinson's disease, and multiple sclerosis. However, living close to green spaces appears to have more of a protective effect against neurodegenerative diseases.

This is a photo of a woman drinking coffee

Featured Genetics Neurology Neuroscience Neuroscience Videos

·January 20, 2020·4 min read

How coffee affects the brain, body, and health

From helping to protect against certain cancers and neurodegenerative diseases to causing anxiety and insomnia, researchers investigate how coffee affects the brain, body, and overall health.

Featured Genetics Neurology Neuroscience Open Neuroscience Articles

·January 17, 2020·3 min read

New insights into a Parkinson’s disease protein

Alpha synuclein's non-amyloidal component (NAC) aids the protein's movement through axons. When the NAC region is removed, alpha-synuclein did not move within axons.

Featured Neurology Neuroscience Open Neuroscience Articles

·January 14, 2020·3 min read

Probiotic could guard against Parkinson’s

Building on previous research that links gut bacteria to the development of Parkinson's disease, researchers identified a probiotic which prevents the formation of alpha-synuclein.

Featured Genetics Neurology Neuroscience Open Neuroscience Articles

·January 5, 2020·5 min read

Up to 10,000 people could be living with rare neurological disorders

Progressive supranuclear palsy (PSP) and corticobasal syndrome (CBS), two atypical parkinsonian syndromes, may be twice as common as previously believed, researchers report.

This is a chemical stick and ball model of dopamine

Featured Neurology Neuroscience Psychology

·December 27, 2019·4 min read

Dopamine fasting: an expert reviews the latest craze in Silicon Valley

The latest Silicon Valley crazy of dopamine fasting promises to "reset" the brain to be more effective and appreciate the smaller things in life more easily, but does it work? Researchers look at the effect of dopamine fasting on brain health.

Featured Neurology Neuroscience Open Neuroscience Articles

·December 20, 2019·3 min read

Scientists discover medicinal cannabis substitute for treating Parkinson’s disease

HU-308, a cannabis substitute, can reduce L-dopa induced dyskinesia in Parkinson's patients.

Featured Neurology Neuroscience

·November 22, 2019·4 min read

Increased use of antibiotics may predispose to Parkinson’s disease

Excessive exposure to certain antibiotics can predispose a person to Parkinson's disease, with a delay of onset of up to 15 years.

Featured Neurology Neuroscience Open Neuroscience Articles

·November 15, 2019·4 min read

Fecal transplantation to treat patients with Parkinson’s disease: Hope or hype?

Study reflects on the possible use of fecal microbiome transplants and pre/probiotics to help with the treatment of Parkinson's disease. Findings reveal fecal transplants have not yet been proven to be effective for motor symptoms associated with the condition, and probiotics have only been shown to assist with constipation.

Featured Neurology Neuroscience Open Neuroscience Articles

·November 14, 2019·4 min read

Targeting alpha-synuclein in the gut may slow down Parkinson’s disease

Scientists are conducting experiments to see if targeting the enteric nervous system with a compound can inhibit the aggregation of alpha-synuclein and slow the progression of Parkinson's disease.

1 … 26 27 28 29 30 … 77

Parkinson’s disease

New mathematical model for amyloid formation

Parkinson’s disease may start before birth

Living near major roads linked to risk of dementia, Parkinson’s, Alzheimer’s and MS

How coffee affects the brain, body, and health

New insights into a Parkinson’s disease protein

Probiotic could guard against Parkinson’s

Up to 10,000 people could be living with rare neurological disorders

Dopamine fasting: an expert reviews the latest craze in Silicon Valley

Scientists discover medicinal cannabis substitute for treating Parkinson’s disease

Increased use of antibiotics may predispose to Parkinson’s disease

Fecal transplantation to treat patients with Parkinson’s disease: Hope or hype?

Targeting alpha-synuclein in the gut may slow down Parkinson’s disease

Hearing Aids Linked to 23% Lower Dementia Risk in Epilepsy

Reading Is the Ultimate Cognitive Enhancer

Dual Brain-Machine Interfaces Unlock Bionic Hand Kinesthesia

Overcoming Endothelial Sorting to Cure Glioblastoma

Subscribe